Clinical trial
Ketamine's Actions on Rumination Mechanisms as an Antidepressant
NCT04656886 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketamine's Actions on Rumination Mechanisms as an Antidepressant
- Lead sponsor
- King's College London
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- May 31, 2018
- Enrollment
- 37 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
remission in depression